Rice University — sometimes known as the "Ivy League of the South" — has been ranked as the best school in the Lone Star State. Courtesy of Rice University

By any measure, Rice University is a top-tier academic institution, lauded locally and nationally for its innovative tuition programs and for boasting the highest-paid graduates in the state. Now, a new ranking names the "Ivy League of the South" the top university in Texas.

Personal finance website WalletHub has released its 2020's Best College & University Rankings, just in time for the looming November 1 "early decision" college application deadline. Rice takes the No. 1 Texas spot and comes in at No. 13 overall in the U.S.

In order to determine the rankings, WalletHub compared more than 1,000 colleges and universities across seven key dimensions: student selectivity, cost and financing, faculty resources, campus safety, campus experience, educational outcomes, and career outcomes.

Among Texas schools, Rice comes in first for the following individual metrics: admission rate, student-faculty ratio, graduation rate, and post-attendance median salary. The school places second for gender and racial diversity.

The University of Texas at Austin follows as the No. 2 best school in Texas, while Trinity University comes in third. Here are the top 10 schools in Texas, according to WalletHub:

  1. Rice University
  2. University of Texas at Austin
  3. Trinity University
  4. Baylor University
  5. LeTourneau University
  6. Texas Christian University
  7. Texas A&M University-College Station
  8. University of Dallas
  9. Southwestern University
  10. Southern Methodist University

At No. 13 on the overall list, Rice shares the spotlight with prestigious institutions, coming in behind the Massachusetts Institute of Technology, Harvard University, Princeton University, Yale University, Stanford University, the California Institute of Technology, Duke University, University of Pennsylvania, Northwestern University, University of North Carolina — Chapel Hill, Vanderbilt University, and Columbia University. University of Chicago is No. 14.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.